Infections

Infectious Disease·MeSH: Infections

Prevalence

808.6 / 100K

Incidence

52631.3 / 100K/yr

157 drugs in development·85 companies·4 clinical trials

Drug Pipeline by Phase

Approved(51)

Drug	Company
amoxicillin	Aptinyx Inc. (APTX)
amoxicillin	Miromatrix Medical Inc. (MIRO)
amoxicillin	SUNSET ISLAND GROUP (SUN)
azithromycin	SUNSET ISLAND GROUP (SUN)
azithromycin	GT Biopharma, Inc. (GTBP)
azithromycin	Aptinyx Inc. (APTX)
banlangen granules	Fuss Brands Corp. (FBDS)
baxdela	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)
Cefaclor Dispersible Tablets	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cefalexin Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	SUNSET ISLAND GROUP (SUN)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
clarithromycin	SUNSET ISLAND GROUP (SUN)
compound honeysuckle granules	Fuss Brands Corp. (FBDS)
daptomycin	MAIA Biotechnology, Inc. (MAIA)
dificid	Curative Biotechnology Inc (CUBT)
Double - Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
Double-Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
doxycycline	Mylan II B.V. (MYL)
doxycycline hyclate	Prestige Consumer Healthcare Inc. (PBH)
emblaveo	AbbVie Inc. (ABBV)
erythromycin lactobionate	NEXUS BIOPHARMA INC (NEXS)
Exelderm	Journey Medical Corp (DERM)
fluconazole	ANI PHARMACEUTICALS INC (ANIP)
metronidazole in plastic container	Amneal Pharmaceuticals, Inc. (AMRX)
minocin	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)
minocycline	NEXUS BIOPHARMA INC (NEXS)
Noxafil	Merck & Co., Inc. (MRK)
orbactiv	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)
orlynvah	Iterum Therapeutics plc (ITRM)
qing re jie du oral liquid	Fuss Brands Corp. (FBDS)
s1 panel assay	NANOMIX CORP (BTHI)
sivextro	Curative Biotechnology Inc (CUBT)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)
tri-heart plus chewable	HESKA CORP (HSKA)
xerava	LA JOLLA PHARMACEUTICAL CO (LJPC)
xerava	TETRAPHASE PHARMACEUTICALS INC (TTPH)
XERAVA	Innoviva, Inc. (INVA)
XERAVA®	Innoviva, Inc. (INVA)
zemdri	Achaogen, Inc. (AKAO)
zerbaxa	Curative Biotechnology Inc (CUBT)
Zerbaxa	Merck & Co., Inc. (MRK)
zevtera	Innoviva, Inc. (INVA)
ZEVTERA®	Innoviva, Inc. (INVA)

Phase 3(18)

Drug	Company
20vpcv	Sanofi (SNY)
ALIS	INSMED Inc (INSM)
Azithromycin	INSMED Inc (INSM)
AZM Group	INSMED Inc (INSM)
catheter lock	CorMedix Inc. (CRMD)
ELC	INSMED Inc (INSM)
eravacycline	TETRAPHASE PHARMACEUTICALS INC (TTPH)
Ethambutol	INSMED Inc (INSM)
formulation buffer	NOVAVAX INC (NVAX)
iv eravacycline	TETRAPHASE PHARMACEUTICALS INC (TTPH)
LAI plus multi-drug regimen	INSMED Inc (INSM)
nirsevimab	ASTRAZENECA PLC (AZN)
nuzyra	Paratek Pharmaceuticals, Inc. (PRTK)
pcv21	Sanofi (SNY)
rezzayo	CorMedix Inc. (CRMD)
rsv f vaccine with adjuvant	NOVAVAX INC (NVAX)
sul-dur	Entasis Therapeutics Holdings Inc. (ETTX)
tebipenem hbr	Spero Therapeutics, Inc. (SPRO)

Phase 2(16)

Drug	Company
Amoxicillin	CYTOKINETICS INC (CYTK)
AP-PA02	Armata Pharmaceuticals, Inc. (ARMP)
AR-501	Aridis Pharmaceuticals, Inc. (ARDS)
bivalent norovirus vaccine candidate	Vaxart, Inc. (VXRT)
eravacycline	ARS Pharmaceuticals, Inc. (SPRY)
investigational oral vaccine candidate for covid-19	Vaxart, Inc. (VXRT)
oritavancin	TG THERAPEUTICS, INC. (TGTX)
Poly ICLC	Crinetics Pharmaceuticals, Inc. (CRNX)
Probiotic	CYTOKINETICS INC (CYTK)
Probiotic	INSMED Inc (INSM)
seasonal influenza vaccine candidate	Vaxart, Inc. (VXRT)
spr206	Spero Therapeutics, Inc. (SPRO)
vabomere	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)
Vitamin D	INSMED Inc (INSM)
Vitamin D	CYTOKINETICS INC (CYTK)
Vonoparazan	CYTOKINETICS INC (CYTK)

Phase 1(28)

Drug	Company
3M-05-AF	Valneva SE (VALN)
3M-052-AF	Valneva SE (VALN)
3M-052-AF	DYNAVAX TECHNOLOGIES CORP (DVAX)
9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use	Design Therapeutics, Inc. (DSGN)
Alum	DYNAVAX TECHNOLOGIES CORP (DVAX)
Aluminum hydroxide suspension	Valneva SE (VALN)
Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
Azithromycin Pill	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
BG505 SOSIP.664 gp140	DYNAVAX TECHNOLOGIES CORP (DVAX)
c-scape	Achaogen, Inc. (AKAO)
CD40.HIVRI.Env	Crinetics Pharmaceuticals, Inc. (CRNX)
CH505 TF chTrimer	Valneva SE (VALN)
DVX201 (Unmodified Natural Killer Cells)	Coeptis Therapeutics Holdings Inc. (COEP)
etx0282cpdp	Entasis Therapeutics Holdings Inc. (ETTX)
GLA-LSQ	DYNAVAX TECHNOLOGIES CORP (DVAX)
Hiltonol Poly-ICLC-adjuvant	Crinetics Pharmaceuticals, Inc. (CRNX)
Influenza A/Texas/71/2017	UNITED THERAPEUTICS Corp (UTHR)
jl18008	Day One Biopharmaceuticals, Inc. (DAWN)
mRNA-1645-CoreG28v2	Cidara Therapeutics, Inc. (CDTX)
mRNA-1645-eODGT8	Cidara Therapeutics, Inc. (CDTX)
mRNA-1645-N332GT5	Cidara Therapeutics, Inc. (CDTX)
omadacycline	Paratek Pharmaceuticals, Inc. (PRTK)
omadacycline injection [nuzyra]	Paratek Pharmaceuticals, Inc. (PRTK)
SER-147	Seres Therapeutics, Inc. (MCRB)
Trimer 4571	DYNAVAX TECHNOLOGIES CORP (DVAX)
virus specific t cells	GH Research PLC (GHRS)
vxa g1.1 nn-t	Vaxart, Inc. (VXRT)
vxa g2.4 ns-t	Vaxart, Inc. (VXRT)

Preclinical(21)

Drug	Company
alvr107	Kalaris Therapeutics, Inc. (KLRS)
anti-infective antibody	XBiotech Inc. (XBIT)
Anti-Rejection Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
AR-201	Aridis Pharmaceuticals, Inc. (ARDS)
AR-401	Aridis Pharmaceuticals, Inc. (ARDS)
autovac	Orgenesis Inc. (ORGS)
bx011	BiomX Inc. (PHGE)
dpp respiratory antigen panel	CHEMBIO DIAGNOSTICS, INC. (CEMI)
emricasan	Histogen Inc. (HSTO)
equivir	IMPACT BIOMEDICAL INC. (IBO)
hemopurifier	Aethlon Medical Inc. (AEMD)
kb174	Kaleido Biosciences, Inc. (KLDO)
nano-mupirocin	Revium Rx. (RVRC)
np-300	Jaguar Health, Inc. (JAGX)
nv-387-ribvp	NANOVIRICIDES, INC. (NNVC)
nv-387-rp	NANOVIRICIDES, INC. (NNVC)
prv-101	PROVENTION BIO, INC. (PBI)
sb019	NVN Liquidation, Inc. (NOVN)
sbfm-pl4	SUNSHINE BIOPHARMA INC. (SBFM)
tellurium based compounds	Qrons Inc. (QRON)
vby329	Invivyd, Inc. (IVVD)

Unknown(8)

Drug	Company
Ainos Flora (VOC POCT)	Ainos Inc. (AIMD)
Alinity® m and m2000™	ABBOTT LABORATORIES (ABT)
amphotericin b liposome for injection (strength	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
amphotericin b liposome for injection (strength	NYMOX PHARMACEUTICAL CORP (NYMXF)
amphotericin b liposome for injection (trade name	NYMOX PHARMACEUTICAL CORP (NYMXF)
amphotericin b liposome for injection (trade name	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
label chg for erika model 9608 arterial blood line	National Research Corporation Common Stock (Delaware) (NRC)
Mino-Lok	Citius Pharmaceuticals, Inc. (CTXR)

BLA Filed(1)

Drug	Company
plazomicin	Achaogen, Inc. (AKAO)

Early Phase 1(1)

Drug	Company
VTP-400	Barinthus Biotherapeutics plc. (BRNS)

N/A(1)

Drug	Company
PrEP for participants without HIV	BIOMERICA INC (BMRA)

Phase 1/Phase 2(4)

Drug	Company
AP-PA03	Armata Pharmaceuticals, Inc. (ARMP)
norovirus gi.1 norwalk virus inoculum	Vaxart, Inc. (VXRT)
vxa-g1.1-nn	Vaxart, Inc. (VXRT)
vxa-g2.4-ns	Vaxart, Inc. (VXRT)

Phase 4(8)

Drug	Company
14-day fecal molecular susceptibility-guided therapy	Bausch Health Companies Inc. (BHC)
7-day fecal molecular susceptibility-guided therapy	Bausch Health Companies Inc. (BHC)
Amoxicillin	INSMED Inc (INSM)
Cabotegravir Injection	COLLEGIUM PHARMACEUTICAL, INC (COLL)
Cabotegravir Pill	COLLEGIUM PHARMACEUTICAL, INC (COLL)
collection of samples	Emergent BioSolutions Inc. (EBS)
sample collection	Emergent BioSolutions Inc. (EBS)
Vonoparazan	INSMED Inc (INSM)

Compare drugs

amoxicillin vs azithromycin amoxicillin vs banlangen granules amoxicillin vs baxdela

Frequently asked questions

How many drugs are in development for Infections?

BioSniper tracks 157 drugs in development for Infections across 85 companies.

How many clinical trials target Infections?

There are 4 clinical trials targeting Infections tracked by BioSniper.

What is the prevalence of Infections?

The estimated prevalence of Infections is approximately 808.6 per 100,000 population.

Deep-dive into Infections

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis